A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming. 2017

G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia.

Essentials Russell's viper envenoming is a major health issue in South Asia and causes coagulopathy. We studied the effect of fresh frozen plasma and two antivenom doses on correcting coagulopathy. Fresh frozen plasma did not hasten recovery of coagulopathy. Low-dose antivenom did not worsen coagulopathy. Background Russell's viper (Daboia russelii) envenoming is a major health issue in South Asia and causes venom-induced consumption coagulopathy (VICC). Objectives To investigate the effects of fresh frozen plasma (FFP) and two antivenom doses in correcting VICC. Methods We undertook an open-label randomized controlled trial in patients with VICC at two Sri Lankan hospitals. Patients with suspected Russell's viper bites and coagulopathy were randomly allocated (1 : 1) to high-dose antivenom (20 vials) or low-dose antivenom (10 vials) plus 4 U of FFP. The primary outcome was the proportion of patients with an International Normalized Ratio (INR) of < 2 at 6 h after antivenom administration. Secondary outcomes included anaphylaxis, major hemorrhage, death, and clotting factor recovery. Results From 214 eligible patients, 141 were randomized: 71 to high-dose antivenom, and 70 to low-dose antivenom/FFP; five had no post-antivenom blood tests. The groups were similar except for a delay of 1 h in antivenom administration for FFP patients. Six hours after antivenom administration, 23 of 69 (33%) patients allocated to high-dose antivenom had an INR of < 2, as compared with 28 of 67 (42%) allocated to low-dose antivenom/FFP (absolute difference 8%; 95% confidence interval - 8% to 25%). Fifteen patients allocated to FFP did not receive it. Severe anaphylaxis occurred equally frequently in each group. One patient given FFP developed transfusion-related acute lung injury. Three deaths occurred in low-dose antivenom/FFP patients, including one intracranial hemorrhage. There was no difference in recovery rates of INR or fibrinogen, but there was more rapid initial recovery of factor V and FX in FFP patients. Conclusion FFP after antivenom administration in patients with Russell's viper bites did not hasten recovery of coagulopathy. Low-dose antivenom/FFP did not worsen VICC, suggesting that low-dose antivenom is sufficient.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
January 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
March 2014, The Ceylon medical journal,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
December 2016, PLoS neglected tropical diseases,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
January 2022, Frontiers in medicine,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
June 2016, Clinical toxicology (Philadelphia, Pa.),
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
June 2022, Toxicon : official journal of the International Society on Toxinology,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
January 2019, Toxicology reports,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
July 2022, The American journal of cardiology,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
June 2023, Toxicon : official journal of the International Society on Toxinology,
G K Isbister, and S Jayamanne, and F Mohamed, and A H Dawson, and K Maduwage, and I Gawarammana, and D G Lalloo, and H J de Silva, and F E Scorgie, and L F Lincz, and N A Buckley
January 2014, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!